| BioCyc:HUMAN_PWY66-378 |
androgen biosynthesis |
| BioCyc:META_PWY66-380 |
estradiol biosynthesis I (via estrone) |
| BioCyc:META_PWY-6074 |
zymosterol biosynthesis |
| BioCyc:MOUSE_PWY66-3 |
cholesterol biosynthesis II (via 24,25-dihydrolanosterol) |
| BioCyc:HUMAN_PWY66-5 |
superpathway of cholesterol biosynthesis |
| BioCyc:HUMAN_PWY66-341 |
cholesterol biosynthesis I |
| BioCyc:META_PWY66-341 |
cholesterol biosynthesis I |
| BioCyc:META_PWY66-4 |
cholesterol biosynthesis III (via desmosterol) |
| BioCyc:YEAST_ERGOSTEROL-SYN-PWY |
superpathway of ergosterol biosynthesis |
| BioCyc:MOUSE_PWY66-341 |
cholesterol biosynthesis I |
| BioCyc:HUMAN_PWY66-3 |
cholesterol biosynthesis II (via 24,25-dihydrolanosterol) |
| BioCyc:HUMAN_PWY-6074 |
zymosterol biosynthesis |
| BioCyc:HUMAN_PWY66-380 |
estradiol biosynthesis I |
| BioCyc:META_PWY66-378 |
androgen biosynthesis |
| BioCyc:META_PWY66-3 |
cholesterol biosynthesis II (via 24,25-dihydrolanosterol) |
| BioCyc:HUMAN_PWY66-4 |
cholesterol biosynthesis III (via desmosterol) |
| BioCyc:HUMAN_PWY-7299 |
progesterone biosynthesis |
| BioCyc:META_PWY-7299 |
progesterone biosynthesis |
| BioCyc:META_ERGOSTEROL-SYN-PWY |
superpathway of ergosterol biosynthesis I |
| BioCyc:META_PWY66-5 |
superpathway of cholesterol biosynthesis |
| BioCyc:YEAST_PWY-6074 |
zymosterol biosynthesis |
| BioCyc:MOUSE_PWY66-4 |
cholesterol biosynthesis III (via desmosterol) |
| Reactome:R-HSA-9757110 |
Prednisone ADME |
| Reactome:R-HSA-9748784 |
Drug ADME |
| Reactome:R-HSA-6807047 |
Cholesterol biosynthesis via desmosterol (Bloch pathway) |
| Reactome:R-HSA-194002 |
Glucocorticoid biosynthesis |
| Reactome:R-MMU-1430728 |
Metabolism |
| Reactome:R-MMU-556833 |
Metabolism of lipids |
| Reactome:R-MMU-8957322 |
Metabolism of steroids |
| Reactome:R-RNO-6807062 |
Zymostenol biosynthesis via lathosterol (Kandutsch-Russell pathway) |
| Reactome:R-HSA-556833 |
Metabolism of lipids |
| Reactome:R-HSA-191273 |
Cholesterol biosynthesis |
| Reactome:R-MMU-6807062 |
Zymostenol biosynthesis via lathosterol (Kandutsch-Russell pathway) |
| Reactome:R-RNO-6807047 |
Cholesterol biosynthesis via desmosterol (Bloch pathway) |
| Reactome:R-HSA-6807062 |
Zymostenol biosynthesis via lathosterol (Kandutsch-Russell pathway) |
| Reactome:R-HSA-193993 |
Mineralocorticoid biosynthesis |
| Reactome:R-MMU-191273 |
Cholesterol biosynthesis |
| Reactome:R-RNO-1430728 |
Metabolism |
| Reactome:R-RNO-556833 |
Metabolism of lipids |
| Reactome:R-RNO-8957322 |
Metabolism of steroids |
| Reactome:R-HSA-1430728 |
Metabolism |
| Reactome:R-HSA-8957322 |
Metabolism of steroids |
| Reactome:R-HSA-196071 |
Metabolism of steroid hormones |
| Reactome:R-HSA-193048 |
Androgen biosynthesis |
| Reactome:R-MMU-6807047 |
Cholesterol biosynthesis via desmosterol (Bloch pathway) |
| Reactome:R-RNO-191273 |
Cholesterol biosynthesis |
| WikiPathways:WP5287 |
17q12 copy number variation syndrome |
| WikiPathways:WP5280 |
Glucocorticoid biosynthesis |
| WikiPathways:WP5368 |
Sulfatase and aromatase pathway |
| WikiPathways:WP5354 |
Ergosterol biosynthesis |
| PathBank:SMP0120794 |
Mevalonic Aciduria |
| PathBank:SMP0121057 |
Bloch Pathway (Cholesterol Biosynthesis) |
| PathBank:SMP0121126 |
Aldosterone from Steroidogenesis |
| PathBank:SMP0000023 |
Steroid Biosynthesis |
| PathBank:SMP0000068 |
Androgen and Estrogen Metabolism |
| PathBank:SMP0000387 |
CHILD Syndrome |
| PathBank:SMP0000373 |
Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency |
| PathBank:SMP0000112 |
Risedronate Action Pathway |
| PathBank:SMP0000508 |
Cholesteryl Ester Storage Disease |
| PathBank:SMP0000576 |
21-Hydroxylase Deficiency (CYP21) |
| PathBank:SMP0000718 |
3-beta-Hydroxysteroid Dehydrogenase Deficiency |
| PathBank:SMP0002438 |
Cholesterol Biosynthesis and Metabolism CE(12:0) |
| PathBank:SMP0087326 |
Steroid Biosynthesis |
| PathBank:SMP0120685 |
Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2) |
| PathBank:SMP0120769 |
Hypercholesterolemia |
| PathBank:SMP0120793 |
Hyper-IgD Syndrome |
| PathBank:SMP0000356 |
17-beta Hydroxysteroid Dehydrogenase III Deficiency |
| PathBank:SMP0000389 |
Smith-Lemli-Opitz Syndrome (SLOS) |
| PathBank:SMP0000319 |
Lysosomal Acid Lipase Deficiency (Wolman Disease) |
| PathBank:SMP0000082 |
Simvastatin Action Pathway |
| PathBank:SMP0000111 |
Cerivastatin Action Pathway |
| PathBank:SMP0000131 |
Atorvastatin Action Pathway |
| PathBank:SMP0000511 |
Wolman Disease |
| PathBank:SMP0000575 |
11-beta-Hydroxylase Deficiency (CYP11B1) |
| PathBank:SMP0000717 |
Apparent Mineralocorticoid Excess Syndrome |
| PathBank:SMP0002381 |
Steroid Biosynthesis |
| PathBank:SMP0002436 |
Cholesterol biosynthesis and metabolism CE(10:0) |
| PathBank:SMP0002441 |
Cholesterol biosynthesis and metabolism CE(18:0) |
| PathBank:SMP0120684 |
CHILD Syndrome |
| PathBank:SMP0120692 |
Desmosterolosis |
| PathBank:SMP0120732 |
Lysosomal Acid Lipase Deficiency (Wolman Disease) |
| PathBank:SMP0120792 |
Cholesteryl Ester Storage Disease |
| PathBank:SMP0070041 |
Cholesterol Biosynthesis and Metabolism |
| PathBank:SMP0121060 |
Kandutsch-Russell Pathway (Cholesterol Biosynthesis) |
| PathBank:SMP0000130 |
Steroidogenesis |
| PathBank:SMP0000386 |
Desmosterolosis |
| PathBank:SMP0000089 |
Pravastatin Action Pathway |
| PathBank:SMP0000095 |
Alendronate Action Pathway |
| PathBank:SMP0000371 |
Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH |
| PathBank:SMP0000099 |
Lovastatin Action Pathway |
| PathBank:SMP0000117 |
Pamidronate Action Pathway |
| PathBank:SMP0000509 |
Hyper-IgD Syndrome |
| PathBank:SMP0000565 |
Aromatase Deficiency |
| PathBank:SMP0000577 |
Corticosterone Methyl Oxidase I Deficiency (CMO I) |
| PathBank:SMP0120735 |
Smith-Lemli-Opitz Syndrome (SLOS) |
| PathBank:SMP0120795 |
Wolman Disease |
| PathBank:SMP0000388 |
Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2) |
| PathBank:SMP0000079 |
Ibandronate Action Pathway |
| PathBank:SMP0000092 |
Rosuvastatin Action Pathway |
| PathBank:SMP0000372 |
Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency |
| PathBank:SMP0000209 |
Hypercholesterolemia |
| PathBank:SMP0000107 |
Zoledronate Action Pathway |
| PathBank:SMP0000119 |
Fluvastatin Action Pathway |
| PathBank:SMP0000510 |
Mevalonic Aciduria |
| PathBank:SMP0000566 |
17-alpha-Hydroxylase Deficiency (CYP17) |
| PathBank:SMP0000578 |
Corticosterone Methyl Oxidase II Deficiency (CMO II) |
| PathBank:SMP0002435 |
Cholesterol biosynthesis and metabolism CE(14:0) |
| PathBank:SMP0002440 |
Cholesterol Biosynthesis and Metabolism CE(16:0) |